Jacelyn Emily Peabody Lever

9PUBLICATIONS
35CO-AUTHORS
Nutrigenomics and personalised nutritionPredictive and prognostic markersMechanobiologyMicroelectromechanical systems (MEMS)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 09, 2024
ACE-2 Blockade & TMPRSS2 Inhibition Mitigate SARS-CoV-2 Severity Following Cigarette Smoke Exposure in Airway Epithelial Cells In Vitro.

Shah S Hussain, Emily Falk Libby, Jacelyn E Peabody Lever

|Jun 19, 2024
Pulmonary Fibrosis Ferret Model Demonstrates Sustained Fibrosis, Restrictive Physiology, and Aberrant Repair.

Jacelyn E Peabody Lever, Qian Li, Nikoleta Pavelkova

|Jun 11, 2024
Metachrony drives effective mucociliary transport via a calcium-dependent mechanism.

Jacelyn E Peabody Lever, K Brett Turner, Courtney M Fernandez

|Feb 22, 2023
Mucociliary clearance augmenting drugs block SARS-CoV-2 replication in human airway epithelial cells.

Javier Campos-Gómez, Courtney Fernandez Petty, Marina Mazur

|Oct 26, 2022
A high-resolution 3D atlas of the spectrum of tuberculous and COVID-19 lung lesions.

Gordon Wells, Joel N Glasgow, Kievershen Nargan

Pageof 2